Stephen H. Sands
CIK 1913319 · last filed 2026-01-06
Stephen H. Sands is a corporate insider who has filed 6 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for BCYC, was dated Jan 6, 2026. Current disclosed insider exposure totals $108.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$108.9K
2
6
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCYC | Director | 26,893 | $4.05 | $108.9K | $0 | 3 | 2026-01-06 |
| Cyteir Therapeutics, Inc. (CYT) Delisted | Director | 12,129 | $3.02 | $36.6K | $0 | 3 | 2024-02-14 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-06 | BCYC | Grant (A) | +9,500 | $0 | EDGAR |
| 2025-01-06 | BCYC | Grant (A) | +5,393 | $0 | EDGAR |
| 2024-02-21 | BCYC | Grant (A) | +12,000 | $0 | EDGAR |
| 2024-02-14 | Cyteir Therapeutics, Inc. (CYT) Delisted | Exer (M) | +12,129 | $20.5K | EDGAR |
| 2023-02-07 | Cyteir Therapeutics, Inc. (CYT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-24 | Cyteir Therapeutics, Inc. (CYT) Delisted | Grant (A) | — | $0 | EDGAR |